Watch Video
trt - 1:34


web | print
Dr. Winnie King consulting with a smoking patient about birth control options.

OTSP - On The Scene Productions, Inc.
 

WOMEN WHO SMOKE WHILE USING HORMONAL BIRTH CONTROL ARE GAMBLING WITH THEIR HEALTH
New survey shows that majority of female smokers continue to do so despite risks

Smoking while on birth control containing hormones like The Pill, Patch or Ring may increase the risk of serious health problems, such as blood clots, stroke and heart attack. A recent survey reveals that eight out of ten women smokers continued to do so even though they were aware of the risks associated with this behavior.1

Survey Highlights:

» Ninety percent of women who smoke said they were aware of these risks2, yet 88 percent of women who have smoked while using hormonal birth control continued to do so despite these risks.3
» Almost half of women who smoke reported that they have not had a conversation with their healthcare providers about the risks of smoking while on a hormonal birth control.4
» Nearly 60 percent of the women surveyed were not aware that there is a safe and highly effective, non-hormonal, birth control option available as an alternative for women smokers.5
» Seventy-eight percent of women who currently smoke describe themselves as heavy smokers (more than one pack per week), while 14 percent say they are moderate smokers (less than one pack per week) and only 8 percent say they are light/social smokers (less than one pack per month).6

“These numbers are absolutely alarming to me,” says Winnie King, MD, Emergency Room Physician at Memorial Hermann Hospital and St. Luke’s Episcopal Hospital in The Woodlands, Texas. “I tell my patients, don’t smoke, period. However, if you do, don’t take the risk of jeopardizing your health further by taking hormonal birth control. There are safe, long-term birth control options available to women who smoke such as the non-hormonal IUC, ParaGard®, which is more than 99% effective.”

About the Survey
The online survey, conducted by a reputable global marketing research company on behalf of Duramed Pharmaceuticals, asked 625 female smokers and ex-smokers, ages 30-45, about their smoking habits.

Safety Information
ParaGard® does not protect against HIV or STDs. You may have heavier or longer periods or spotting between periods, which usually subsides after 2-3 months. Complications may occur from placement. You must not use ParaGard if you have pelvic inflammatory disease (PID) or engage in behavior putting you at high risk for PID, have a history of certain reproductive cancers or infections, have Wilson's disease, or might be pregnant.

Marketing Information
ParaGard® is marketed by Duramed Pharmaceuticals, Inc., the U.S. proprietary (branded) pharmaceutical subsidiary of Barr Pharmaceuticals, Inc., a global specialty pharmaceutical company that operates in more than 30 countries.

Please see full Prescribing Information. For more information, please visit www.ParaGard.com.

B Roll Hard Copies Available Upon Request, Please Contact:

Lauren Barrish or Michelle Yered
Communications Strategies, Inc.
973-635-6669

1-6 Online Survey “A Study Among Women Smokers About Hormonal Contraceptive Usage.” Conducted by Synovate Health Care, November 2007

# # #